Number of the records: 1
dabigatran
SYS d000069604 LBL 00000nz--a2200181n--4500 005 20250606221752.5 008 160101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $a BA006 065 $a D03.383.725.192 065 $a D03.633.100.103.280 066 $a 01 $c 03 150 $a dabigatran $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a dabigatran etexilát $2 slo 450 $w v $a dabigatran etexilát mezylát $2 slo 550 $7 sllk_us_auth*d000991 $Y Antithrombins $w P $a antitrombíny 665 $a 2016 (2002) $2 eng 680 9-
$i A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation. $2 eng 750 -2
$a Dabigatran $2 eng 980 $x M
Number of the records: 1